skip to Main Content

Ipreo Daily Market Update October 2, 2015

In U.S. economic news, personal income for August rose 0.3%, below the upwardly-revised increase of 0.5% in July from 0.4%, while personal spending grew 0.4%. Meanwhile, Eurozone retail sales remained flat in August following July’s upwardly-revised 0.6% increase, and topping economists’ expectations of a 0.1% decline. Elsewhere, Japan’s average household spending rose 2.9% in August, while China’s manufacturing conditions hit the lowest point in six-and-a-half years as weak foreign demand led to dramatically less orders in September.

Ipreo Quarterly US Update: Quarter ending September 30, 2015

Healthcare, once again, proved to be a dominant force for new issuance in Q3 2015, contributing 64 deals for a total of $10.2B in proceeds and accounting for over a third of the quarter’s volume. In the past, we have continually referenced the impressive streak the sector is on, but within this piece we take a closer look at Healthcare deals since 2005 to frame the rise of the sector in today’s market.

Ipreo Early Edition – The Week Ended September 25, 2015

As investors pondered the fallout of the epic debacle that is the Volkswagen emissions scandal, the markets proved to be a far less thrilling avenue as 12 deals priced last week (1 IPO and 11 FOs) and generated $3.0B, coming in ahead of the previous week’s 8 deals for $1.5B. Looking ahead to this week, markets appear to be building up in preparation for the end of the quarter as 9 deals (6 IPOs, 3 FOs) are currently expected to price, with Surgery Partners, Inc.’s $350.0M public debut leading the charge.
Back To Top